UNIVERSAL HEALTH SERVICES INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $17.4B | $15.8B | $14.3B | $13.4B | $12.6B |
| Operating expenses | $15.4B | $14.1B | $13.1B | $12.4B | $11.3B |
| Operating income | $2.0B | $1.7B | $1.2B | $1.0B | $1.4B |
| Interest expense | $156.1M | $186.1M | $206.7M | $126.9M | $83.7M |
| Pretax income | $2.0B | $1.5B | $940.4M | $866.3M | $1.3B |
| Income tax expense | $461.0M | $334.8M | $221.1M | $209.3M | $305.7M |
| Net income | $1.5B | $1.1B | $717.8M | $675.6M | $991.6M |
| Balance Sheet | |||||
| Cash and equivalents | $137.8M | $126.0M | $119.4M | $102.8M | $115.3M |
| Current assets | $3.4B | $2.8B | $2.8B | $2.5B | $2.3B |
| Total assets | $15.5B | $14.5B | $14.0B | $13.5B | $13.1B |
| Current liabilities | $3.2B | $2.2B | $2.0B | $1.9B | $2.0B |
| Total debt | $4.8B | $4.5B | $4.9B | $4.8B | $4.2B |
| Stockholders' equity | $7.3B | $6.7B | $6.1B | $5.9B | $6.1B |
| Cash Flow Statement | |||||
| Cash from operations | $1.9B | $2.1B | $1.3B | $996.0M | $883.7M |
| Depreciation and amortization | $594.0M | $559.6M | $535.6M | $544.0M | $501.6M |
| Stock-based compensation | $95.7M | $99.3M | $87.7M | $85.4M | $73.7M |
| Capital expenditure | $1.0B | $943.8M | $743.1M | $734.0M | $855.7M |
| Free cash flow | $849.2M | $1.1B | $524.7M | $262.0M | $28.0M |
| Dividends paid | $51.3M | $53.3M | $55.5M | $58.4M | $65.9M |
| Share repurchases | $968.0M | $670.8M | $547.4M | $832.9M | $1.2B |
| Impairments | — | $0 | $0 | $57.5M | $14.4M |
Shares outstanding 60.5M · Free float 70.7%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.